Quipt Home Medical Corp.
QIPT · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.21 | -0.14 | 0.48 | -0.18 |
| FCF Yield | 22.43% | 20.20% | 14.88% | 11.92% |
| EV / EBITDA | -31.39 | 4.07 | 6.28 | 5.78 |
| Quality | ||||
| ROIC | -2.85% | 0.54% | 2.84% | 7.35% |
| Gross Margin | 97.53% | 71.97% | 72.65% | 76.25% |
| Cash Conversion Ratio | -3.52 | -5.23 | -9.78 | 3.94 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.05% | 20.70% | 27.41% | 24.10% |
| Free Cash Flow Growth | 1.08% | -16.80% | 75.34% | 25.92% |
| Safety | ||||
| Net Debt / EBITDA | -1.84 | 1.64 | 1.79 | 0.64 |
| Interest Coverage | -0.57 | 0.12 | 0.76 | 2.46 |
| Efficiency | ||||
| Inventory Turnover | 0.24 | 3.31 | 3.14 | 2.13 |
| Cash Conversion Cycle | 1,597.73 | -1.57 | 4.94 | 61.92 |